Option Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of “Moderate Buy” by Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has been assigned an average rating of “Moderate Buy” from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $33.00.

A number of research analysts have commented on the company. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective on the stock. Finally, JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th.

Option Care Health Trading Down 2.0 %

Shares of OPCH opened at $32.24 on Friday. The stock’s 50-day moving average is $30.63 and its two-hundred day moving average is $28.25. The stock has a market cap of $5.33 billion, a PE ratio of 27.09, a P/E/G ratio of 2.30 and a beta of 1.33. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.85. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.64% of the stock is currently owned by insiders.

Institutional Trading of Option Care Health

Several institutional investors and hedge funds have recently bought and sold shares of OPCH. Wellington Management Group LLP raised its stake in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after buying an additional 8,400,208 shares in the last quarter. FMR LLC raised its stake in Option Care Health by 134.0% during the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after buying an additional 4,304,896 shares in the last quarter. Norges Bank acquired a new stake in Option Care Health during the fourth quarter valued at approximately $60,219,000. Victory Capital Management Inc. raised its stake in Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares in the last quarter. Finally, Voloridge Investment Management LLC acquired a new stake in Option Care Health during the fourth quarter valued at approximately $27,428,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.